Ticker history: FLGC became ZSTK (ZeroStack Corp.) on .
Newest figures come from the 10-Q for Q1 FY2026, filed May 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FLGC SEC filings page.
Flora Growth Corp. (FLGC) reported $41.2M in revenue over the twelve months to Mar 31, 2026, up 10.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Flat sales now leave almost no gross profit, while a much larger reported loss is only partly reflected in cash use.
The earnings-to-cash gap widened in FY2025: net loss reached$119.7M versus operating cash flow of-$8.7M , meaning reported losses were far larger than the cash deficit. FY2024 showed the same direction at a$15.9M net loss and-$5.0M operating cash flow, so the latest deterioration was concentrated more in reported earnings than operating cash consumption.
Revenue was essentially flat year over year, yet gross profit fell
The operating loss reached
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Flora Growth Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Flora Growth Corp. held $5.6M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $8.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Flora Growth Corp. scores 26/100 among other emerging companies.
Not available for Flora Growth Corp., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Not available for Flora Growth Corp., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Flora Growth Corp. scores 12/100 on it among other emerging companies.
Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. Flora Growth Corp. scores 47/100 on it among other emerging companies.
Flora Growth Corp.'s cash, cash equivalents and investments came to $5.6M at the end of fiscal year 2025, against $59.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Flora Growth Corp. scores 17/100 among other emerging companies.
Flora Growth Corp. passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Flora Growth Corp. reported a net loss of $119.7M while operations used $8.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Flora Growth Corp. reported an operating loss of $154.7M against $243K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Flora Growth Corp. generated $7.3M in revenue in Q1 2026. This represents an increase of 5.9% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.
Flora Growth Corp.'s EBITDA was -$62.6M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Flora Growth Corp. reported a net loss of $36.7M in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Flora Growth Corp. recorded an outflow of $3.8M in free cash flow in Q1 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Flora Growth Corp. held $2.0M in cash against $38K in long-term debt as of Q1 2026, with $8.1M of liabilities due within a year.
Not reported for Q1 2026.
Margins & Returns
Flora Growth Corp.'s gross margin was 43.3% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 35.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 41.5 percentage points.
Flora Growth Corp.'s quarterly ROE was -99.6% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is down 83.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 56.1 percentage points.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Flora Growth Corp. reported no capital expenditure in Q1 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Not reported for Q1 2026.
Not reported for Q1 2026.
FLGC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.3M+5.9% | $9.4M+22.3% | $9.7M+34.7% | $14.8M-5.7% | $6.9M-61.9% | $7.6M-57.5% | $7.2M-58.2% | $15.7M-26.9% |
| Cost of Revenue | $4.1M-34.8% | $9.2M+24.9% | $9.4M+39.6% | $12.0M-4.4% | $6.3M-55.3% | $7.4M-49.2% | $6.7M-45.5% | $12.5M-28.5% |
| Gross Profit | $3.1M+488.0% | $160K-44.1% | $335K-32.3% | $2.8M-10.6% | $535K-86.1% | $286K-91.8% | $495K-90.0% | $3.2M-20.0% |
| R&D Expenses | N/A | N/A | N/A | $73K+17.7% | $113K+140.4% | $191K+664.0% | $118K+1375.0% | $62K+376.9% |
| SG&A Expenses | N/A | $330K | $473K+15.6% | $760K+29.5% | $470K+6.3% | N/A | $409K+20.3% | $587K-14.3% |
| Operating Income | -$62.7Mn/m | -$147.2Mn/m | -$3.3Mn/m | -$2.6Mn/m | -$1.6Mn/m | -$3.7Mn/m | -$2.1Mn/m | -$3.5Mn/m |
| EBITDA | -$62.6Mn/m | -$147.0M | -$3.3Mn/m | -$2.4Mn/m | -$1.4Mn/m | N/A | -$2.1Mn/m | -$3.3Mn/m |
| Interest Expense | $66K+29.4% | -$137K | -$61Kn/m | -$96K-155.8% | $51K+8.5% | N/A | -$26K | $172K+855.6% |
| Income Tax | -$9K-110.2% | -$54Kn/m | $18Kn/m | -$48Kn/m | $88K-31.3% | -$58Kn/m | -$66Kn/m | -$35Kn/m |
| Net Income | -$36.7Mn/m | -$109.9Mn/m | -$6.7Mn/m | -$2.4Mn/m | -$758Kn/m | -$6.1Mn/m | -$3.8M-405.0% | -$2.6Mn/m |
| EPS (Basic) | -$3.68 | N/A | -$9.05 | -$0.11 | -$1.54 | N/A | -$11.03 | -$0.21 |
| EPS (Diluted) | -$3.68 | N/A | -$9.05 | -$0.11 | -$1.54 | N/A | -$11.03 | -$0.21 |
| Diluted Shares (Avg) | 9,958 | N/A | 736 | 21,454 | 492 | N/A | 342 | 12,278 |
FLGC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.2M+101.8% | $130.2M+396.6% | $74.0M+152.8% | $22.7M-24.7% | $22.4M-7.7% | $26.2M+11.0% | $29.3M-7.3% | $30.1M-1.3% |
| Current Assets | $11.2M-14.9% | $8.7M-55.9% | $18.1M-15.0% | $13.2M-38.2% | $13.2M-39.3% | $19.8M-7.5% | $21.3M-10.8% | $21.4M-4.0% |
| Cash & Equivalents | $2.0M-46.2% | $5.6M+7.1% | $13.1M+211.2% | $1.5M-76.0% | $3.7M-11.5% | $5.2M+20.1% | $4.2M-11.6% | $6.1M+243.8% |
| Inventory | $1.6M-66.4% | $1.9M-15.3% | $2.5M-68.4% | $4.8M-28.8% | $4.8M-48.2% | $2.2M-73.7% | $7.9M-26.1% | $6.7M-22.3% |
| Accounts Receivable | $783K-80.7% | $799K-49.0% | $2.3M-41.6% | $5.1M+55.1% | $4.0M+25.8% | $1.6M-60.3% | $3.9M+10.7% | $3.3M-32.4% |
| Goodwill | N/A | N/A | N/A | $4.7M+104.9% | $4.5M | $2.0Mn/m | $2.1Mn/m | $2.3Mn/m |
| Total Liabilities | $8.4M-52.4% | $59.7M+174.8% | $9.1M-62.3% | $18.6M-14.5% | $17.6M-16.6% | $21.7M+26.1% | $24.1M+30.4% | $21.8M+7.7% |
| Current Liabilities | $8.1M-35.6% | $8.6M-54.2% | $8.7M-58.4% | $13.8M-24.9% | $12.6M-34.8% | $18.8M+15.7% | $20.9M+26.0% | $18.4M+3.1% |
| Non-Current Liabilities | $289K-94.3% | $51.1M+1669.7% | $399K-87.5% | $4.8M+41.2% | $5.0M+177.8% | $2.9M+206.3% | $3.2M+69.0% | $3.4M+41.3% |
| Long-Term Debt | $38K-86.2% | $50.8Mn/m | $64K | $326K | $275K | $0 | N/A | N/A |
| Total Equity | $36.8M+673.4% | $70.6M+1464.3% | $64.9M+1427.5% | $4.0M-45.0% | $4.8M+51.6% | $4.5M-29.6% | $4.3M-70.3% | $7.3M-33.2% |
| Retained Earnings | -$314.4Mn/m | -$277.8Mn/m | -$167.9Mn/m | -$161.3Mn/m | -$158.9Mn/m | -$158.1Mn/m | -$152.0Mn/m | -$148.2Mn/m |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
FLGC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.8Mn/m | -$3.2Mn/m | $100Kn/m | -$3.0Mn/m | -$2.7Mn/m | -$1.3Mn/m | -$2.1M-501.7% | -$265Kn/m |
| Depreciation & Amortization | $4K-97.8% | $198K-6.2% | $7K-12.5% | $195K-24.1% | $182K+145.9% | $211K-41.9% | $8K-97.4% | $257K-70.6% |
| Stock-Based Compensation | $2.8M+1511.0% | N/A | $541K+33.3% | $172K+1333.3% | $172K+1620.0% | N/A | $406K+10050.0% | $12K-96.4% |
| Capital Expenditures | $0-100.0% | $29Kn/m | $9K-55.0% | $65K+150.0% | $24K-72.7% | $0 | $20K+233.3% | $26K-72.0% |
| Free Cash Flow | -$3.8Mn/m | -$3.2Mn/m | $91Kn/m | -$3.0Mn/m | -$2.7Mn/m | -$1.3Mn/m | -$2.1M-510.4% | -$291Kn/m |
| Investing Cash Flow | $0-100.0% | -$2.8Mn/m | -$11K-104.7% | -$1.0M-1929.1% | $370Kn/m | $0-100.0% | $236Kn/m | $55Kn/m |
| Financing Cash Flow | $571Kn/m | -$719K-121.3% | $10.6Mn/m | $1.5M-66.8% | $0n/m | $3.4M+380.5% | -$257K-111.0% | $4.6M+3377.9% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
FLGC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.3%+35.5pp | 1.7%-2.0pp | 3.4%-3.4pp | 19.1%-1.1pp | 7.8%-13.6pp | 3.7%-15.7pp | 6.8%-21.7pp | 20.2%+1.7pp |
| Operating Margin | -861.3% | -3450.6% | -33.5%-4.3pp | -17.3%+5.2pp | -23.6%-9.8pp | -48.4%-7.4pp | -29.2%-26.1pp | -22.6% |
| Net Margin | -504.0% | -2576.3% | -68.3%-16.2pp | -16.3%+0.5pp | -11.0%+7.7pp | -80.2%-23.9pp | -52.1%-59.3pp | -16.8% |
| Return on Equity | -99.6%-83.7pp | -155.8%-19.9pp | -10.3%+78.5pp | -60.0%-24.0pp | -15.9%+91.6pp | -135.9%+21.9pp | -88.8%-97.4pp | -36.0%+369.1pp |
| Return on Assets | -81.1%-77.7pp | -84.4%-61.0pp | -9.0%+3.9pp | -10.6%-1.9pp | -3.4%+10.5pp | -23.4%+19.4pp | -12.9%-16.8pp | -8.7%+136.6pp |
| Current Ratio | 1.39+0.3x | 1.010.0x | 2.08+1.1x | 0.96-0.2x | 1.05-0.1x | 1.05-0.3x | 1.02-0.4x | 1.16-0.1x |
| Debt-to-Equity | 0.00-0.1x | 0.72+0.7x | 0.00 | 0.08 | 0.06 | 0.00 | N/A | N/A |
| Liabilities-to-Equity | 0.23-3.5x | 0.85-4.0x | 0.14-5.5x | 4.63+1.7x | 3.71-3.0x | 4.82+2.1x | 5.67+4.4x | 2.98+1.1x |
| Asset Turnover | 0.16-0.1x | 0.07-0.2x | 0.13-0.1x | 0.65+0.1x | 0.31-0.4x | 0.29-0.5x | 0.25-0.3x | 0.52-0.2x |
| FCF Margin | -52.9%-13.8pp | -34.1%-16.5pp | 0.9%+30.0pp | -20.4%-18.6pp | -39.1%-31.2pp | -17.6%-11.1pp | -29.0%-32.0pp | -1.9%+14.7pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Flora Growth Corp. FLGC | FY2025 | $35.7M | -$119.7M | N/A | N/A | 26/100 |
| Strive, Inc. ASST | FY2024 | $3.6M | -$21.6M | N/A | $2.2B | 46/100 |
| Forward Industries, Inc. FWDI | FY2025 | $18.2M | -$167.0M | N/A | $326.6M | 20/100 |
| Solana Company HSDT | FY2025 | $6.0M | -$40.9M | N/A | $102.5M | 46/100 |
| CaliberCos Inc. CWD | FY2025 | $20.1M | -$21.8M | N/A | $4.1M | 36/100 |
| Blue Owl Capital Corporation OBDC | FY2025 | $1.9B | $627.4M | 33.9% | $5.2B | 44/100 |
Where Flora Growth Corp. Ranks
Frequently Asked Questions
Flora Growth Corp. (FLGC) reported $35.7M in total revenue for fiscal year 2025. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Flora Growth Corp. (FLGC) revenue declined by 0.5% year-over-year, from $35.9M to $35.7M in fiscal year 2025.
No, Flora Growth Corp. (FLGC) reported a net loss of $155.6M over the trailing 12 months to March 31, 2026. In fiscal year 2025 it reported a net loss of $119.7M.
Flora Growth Corp. (FLGC) had EBITDA of -$154.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Flora Growth Corp. (FLGC) had $5.6M in cash and equivalents against $50.8M in long-term debt.
Flora Growth Corp. (FLGC) had a gross margin of 4.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Flora Growth Corp. (FLGC) has a return on equity of -169.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Flora Growth Corp. (FLGC) recorded an outflow of $8.8M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Flora Growth Corp. (FLGC) recorded an outflow of $8.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Flora Growth Corp. (FLGC) had $130.2M in total assets as of fiscal year 2025, including both current and long-term assets.
Flora Growth Corp. (FLGC) invested $127K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Flora Growth Corp. (FLGC) had a current ratio of 1.01 as of fiscal year 2025, which is considered adequate.
Flora Growth Corp. (FLGC) had a debt-to-equity ratio of 0.72 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Flora Growth Corp. (FLGC) had a liabilities-to-equity ratio of 0.85 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Flora Growth Corp. (FLGC) had a return on assets of -91.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Flora Growth Corp. (FLGC) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Flora Growth Corp. (FLGC) reported a net loss of $119.7M while operations used $8.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Flora Growth Corp. (FLGC) reported an operating loss of $154.7M against $243K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Flora Growth Corp. (FLGC) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Flora Growth Corp. it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.